CB-22 is a synthetic cannabinoid compound that acts as a potent agonist at the cannabinoid receptors. It is similar in structure to other synthetic cannabinoids such as JWH-018 and 5F-ADB. However, its effects and potency are not well studied, and it has been associated with adverse health effects and even fatalities in some cases.
The exact mechanism of action of CB-22 is not well understood. It is believed to bind to the cannabinoid receptors in the brain and nervous system, leading to a range of effects including pain relief, relaxation, and altered perception.
CB-22 is considered a highly potent compound and is classified as a Schedule I controlled substance in some jurisdictions. It is often sold under street names such as Blaze and Kronic and can be purchased online or through underground markets.
Due to its potential health risks and lack of regulation, the use of CB-22 and other synthetic cannabinoids is strongly discouraged. Individuals who experience adverse effects after using these substances should seek medical attention immediately.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page